# Inhibitory NK receptor expression associates with altered antimalarial function of γδ T cells

**Authors:** Meagan E. Olive, Perri C. Callaway, Mikias Ilala, Justine Levan, Gonzalo R. Acevedo, Felistas Nankya, Emmanuel Arinaitwe, John Rek, Prasanna Jagannathan, Grant Dorsey, Moses R. Kamya, Margaret E. Feeney

PMC · DOI: 10.1371/journal.ppat.1013460 · PLOS Pathogens · 2026-02-03

## TL;DR

This study explores how inhibitory NK receptors on γδ T cells influence immune responses to malaria in children with high or low exposure.

## Contribution

The study identifies specific inhibitory NK receptors that modulate γδ T cell function in malaria-exposed children.

## Key findings

- NKG2A and KIR3DL1 expression correlates with enhanced γδ T cell responses to malaria antigens.
- KIR2DL1, KIR2DL2/3, and LILRB1 are associated with reduced γδ T cell activity and cytokine production.
- Inhibitory NK receptors regulate γδ T cell function in a finely tuned balance during malaria infection.

## Abstract

Gamma delta (γδ) T cells are important mediators of the immune response to childhood malaria. Human Vγ9+Vδ2+ T cells possess intrinsic, HLA-independent responsiveness to Plasmodium falciparum phosphoantigens produced in the blood stage of malaria. Engagement of the γδ T cell receptor (TCR) by phosphoantigen-bound butyrophilin molecules results in Vγ9+Vδ2+ T cell expansion, pro-inflammatory cytokine production, and release of cytotoxic granules that mediate parasite killing. Repeated P. falciparum infection, however, leads to a reduction in circulating Vγ9+Vδ2+ T cells and upregulation of immunomodulatory molecules, including NK receptors, that correlates with less severe symptoms upon infection. We explore phenotypic and functional differences of γδ T cells in Ugandan children with high versus low malaria exposure, utilizing high-parameter spectral flow cytometry analysis of PBMCs. We observed significant differences in expression of inhibitory NK receptors – KIR2DL1, KIR2DL2/3, KIR3DL1, LILRB1, and NKG2A – on γδ T cell subsets, with Vγ9+Vδ2+ T cells exhibiting a divergent mechanism of control compared to other subsets. We found that NKG2A and KIR3DL1 expression associated with potent Vγ9+Vδ2+ T cell responses to TCR- and Fc receptor (FcR)-mediated stimulation while KIR2DL1, KIR2DL2/3 and LILRB1 associated with reduced degranulation and cytokine production. These results identify a new role for inhibitory NK receptors expressed on γδ T cells, exerting a finely tuned balance of activating and inhibitory signals to regulate the response to malaria-related antigens.

Malaria remains one of the deadliest infectious diseases, disproportionately affecting young children in sub-Saharan Africa who succumb to sequelae of Plasmodium falciparum infection. However, children living in highly endemic areas experience repeated P. falciparum infection and develop naturally acquired–but not sterilizing–immunity which leads to an asymptomatic reinfection pattern. The immune factors that determine the balance of inflammatory and tolerogenic functions seen in non-sterilizing malaria immunity are yet to be fully understood. Here, we focus on the phenotypic and functional differences in one cell type between children with a history of low versus high malaria exposure. We identified a group of inhibitory surface receptors that improved the antimalarial function of this cell, and another group that worsened their function. Our study clarifies the immune landscape in highly malaria-exposed individuals and illuminates one potential system of regulating the cellular response to repeat infection.

## Linked entities

- **Genes:** KIR2DL1 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1) [NCBI Gene 3802], KIR3DL1 (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1) [NCBI Gene 3811], LILRB1 (leukocyte immunoglobulin like receptor B1) [NCBI Gene 10859], KLRC1 (killer cell lectin like receptor C1) [NCBI Gene 3821]
- **Diseases:** malaria (MONDO:0005136)

## Full-text entities

- **Genes:** KIR3DL1 (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1) [NCBI Gene 3811] {aka CD158E1, KIR, KIR3DL1/S1, NKAT-3, NKAT3, NKB1}, LAIR1 (leukocyte associated immunoglobulin like receptor 1) [NCBI Gene 3903] {aka CD305, LAIR-1}, KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914] {aka CD314, D12S2489E, KLR, NKG2-D, NKG2D}, KLRB1 (killer cell lectin like receptor B1) [NCBI Gene 3820] {aka CD161, CLEC5B, NKR, NKR-P1, NKR-P1A, NKRP1A}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, KIR2DL1 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1) [NCBI Gene 3802] {aka CD158A, KIR-K64, KIR221, NKAT, NKAT-1, NKAT1}, CD14 (CD14 molecule) [NCBI Gene 929], CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, KLRC1 (killer cell lectin like receptor C1) [NCBI Gene 3821] {aka CD159A, NKG2, NKG2A}, CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, GNLY (granulysin) [NCBI Gene 10578] {aka D2S69E, LAG-2, LAG2, NKG5, TLA519}, LAMP1 (lysosome associated membrane protein 1) [NCBI Gene 3916] {aka CD107a, LAMPA, LGP120}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, LILRB1 (leukocyte immunoglobulin like receptor B1) [NCBI Gene 10859] {aka CD85J, ILT-2, ILT2, LIR-1, LIR1, MIR-7}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, SPICE1 (spindle and centriole associated protein 1) [NCBI Gene 152185] {aka CCDC52, SPICE}, KIR2DL3 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3) [NCBI Gene 3804] {aka CD158B2, CD158b, GL183, KIR-023GB, KIR-K7b, KIR-K7c}
- **Diseases:** Mtb (MESH:D014376), P. falciparum parasitemia (OMIM:248310), CMV (MESH:D003586), inflammatory complication (MESH:D018746), infectious diseases (MESH:D003141), cancer (MESH:D009369), parasitemia (MESH:D018512), infection (MESH:D007239), inflammatory (MESH:D007249), Malaria (MESH:D008288), P. falciparum infection (MESH:D016778), T (MESH:D001260)
- **Chemicals:** acid citrate dextrose (MESH:C002113), HMBPP (MESH:C443995), carbamate (MESH:D002219), DX17 (-), L-glutamine (MESH:D005973), Brefeldin A (MESH:D020126), nitrogen (MESH:D009584), bendiocarb (MESH:C007725), Pen (MESH:C058388), HEPES (MESH:D006531), carbonate (MESH:D002254), Monensin (MESH:D008985), PBS (MESH:D007854), CO2 (MESH:D002245), (E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate (MESH:C467061), Streptomycin (MESH:D013307), BD (MESH:C028491)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Cytomegalovirus (genus) [taxon 10358], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12880742/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12880742/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12880742/full.md

---
Source: https://tomesphere.com/paper/PMC12880742